Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin

Objective: The primary objective was to assess the warming sensation caused by flavor 316282 in a cold and cough product in the target population. Methods: A single-cohort, single-treatment arm, open-label study. Subjects received one 30-mL dose of syrup containing flavor 316282, paracetamol, phenyl...

Full description

Bibliographic Details
Main Authors: Rowland Furcha, Joëlle Monnet
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312113518198
id doaj-f3b83a22f78548a8b5e97bd8d1e28c67
record_format Article
spelling doaj-f3b83a22f78548a8b5e97bd8d1e28c672020-11-25T04:00:20ZengSAGE PublishingSAGE Open Medicine2050-31212014-01-01210.1177/205031211351819810.1177_2050312113518198Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesinRowland FurchaJoëlle MonnetObjective: The primary objective was to assess the warming sensation caused by flavor 316282 in a cold and cough product in the target population. Methods: A single-cohort, single-treatment arm, open-label study. Subjects received one 30-mL dose of syrup containing flavor 316282, paracetamol, phenylephrine hydrochloride, and guaifenesin and recorded onset and disappearance of any warming sensation in the mouth/throat. Subjects’ assessment of strength and appeal of the sensation, taste, texture, and acceptability of the product as a cold and cough remedy was investigated using questionnaires. Results: A total of 51 subjects were included; 47 (92.1%) experienced a warming sensation. The median duration of the warming sensation was 100 s (95% confidence interval = 82 s, 112 s). The majority of subjects rated the syrup as excellent, good, or fair for treatment of cough and cold symptoms (96.1%), taste (80.4%), and texture (98.0%). There were no safety concerns, and the syrup was well tolerated. Most subjects liked the warming sensation. Conclusions: Flavor 316282 in a cold and cough syrup is associated with a warming sensation. The syrup is well tolerated, safe, and palatable.https://doi.org/10.1177/2050312113518198
collection DOAJ
language English
format Article
sources DOAJ
author Rowland Furcha
Joëlle Monnet
spellingShingle Rowland Furcha
Joëlle Monnet
Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
SAGE Open Medicine
author_facet Rowland Furcha
Joëlle Monnet
author_sort Rowland Furcha
title Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
title_short Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
title_full Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
title_fullStr Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
title_full_unstemmed Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
title_sort clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin
publisher SAGE Publishing
series SAGE Open Medicine
issn 2050-3121
publishDate 2014-01-01
description Objective: The primary objective was to assess the warming sensation caused by flavor 316282 in a cold and cough product in the target population. Methods: A single-cohort, single-treatment arm, open-label study. Subjects received one 30-mL dose of syrup containing flavor 316282, paracetamol, phenylephrine hydrochloride, and guaifenesin and recorded onset and disappearance of any warming sensation in the mouth/throat. Subjects’ assessment of strength and appeal of the sensation, taste, texture, and acceptability of the product as a cold and cough remedy was investigated using questionnaires. Results: A total of 51 subjects were included; 47 (92.1%) experienced a warming sensation. The median duration of the warming sensation was 100 s (95% confidence interval = 82 s, 112 s). The majority of subjects rated the syrup as excellent, good, or fair for treatment of cough and cold symptoms (96.1%), taste (80.4%), and texture (98.0%). There were no safety concerns, and the syrup was well tolerated. Most subjects liked the warming sensation. Conclusions: Flavor 316282 in a cold and cough syrup is associated with a warming sensation. The syrup is well tolerated, safe, and palatable.
url https://doi.org/10.1177/2050312113518198
work_keys_str_mv AT rowlandfurcha clinicalassessmentofthewarmingsensationaccompanyingflavor316282inacoldandcoughsyrupcontainingparacetamolphenylephrinehydrochlorideandguaifenesin
AT joellemonnet clinicalassessmentofthewarmingsensationaccompanyingflavor316282inacoldandcoughsyrupcontainingparacetamolphenylephrinehydrochlorideandguaifenesin
_version_ 1724451207284523008